| URL | https://endpts.com/crispr-therapeutics-blueprints- |
| Source | Endpoints News |
| Date Published | 06/25/2020 |
| Author Name | John Carroll |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | CRISPR Therapeutics |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 100 |
| Year reshoring announced: | 2020 |
| Domestically, the work will be done: | In-house |
| Country(ies) from which reshored: | Switzerland |
| City reshored to: | Framingham |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | cell therapy technologies |